Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000075.xml
Download PDF
Semin Respir Crit Care Med 2015; 36(05): 729-745
DOI: 10.1055/s-0035-1562899
DOI: 10.1055/s-0035-1562899
Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management
Further Information
Publication History
Publication Date:
23 September 2015 (online)
Abstract
Histoplasmosis is the most common endemic mycosis in the North America, Central America, and many countries of South America and also occurs in China, India, Southeast Asia, Africa, Australia, and Europe. Clinical syndromes are not specific and histoplasmosis often is overlooked in the evaluation of patients with community-acquired pneumonia, chronic cavitary pneumonia resembling tuberculosis or anaerobic infection, granulomatous inflammatory diseases such as sarcoidosis or Crohn disease, and malignancy. The diagnosis depends on understanding the geographic distribution, common clinical presentations, and tests used for diagnosis of histoplasmosis. While histoplasmosis resolves without treatment in most patients, treatment is indicated in all immunocompromised patients and those with progressive disseminated disease or chronic pulmonary disease. Treatment is appropriate in most patients with acute pulmonary disease but rarely in those with other pulmonary or mediastinal manifestations. The preferred agents include liposomal amphotericin B for more severe cases and itraconazole for milder cases and “step-down” therapy following response to amphotericin B.
-
References
- 1 Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99 (4) 1-132
- 2 Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 2011; 49 (8) 785-798
- 3 Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis 2010; 51 (5) 561-570
- 4 Damasceno LS, Ramos Jr AN, Alencar CH , et al. Disseminated histoplasmosis in HIV-infected patients: determinants of relapse and mortality in a north-eastern area of Brazil. Mycoses 2014; 57 (7) 406-413
- 5 Nacher M, Adenis A, Mc Donald S , et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 2013; 7 (11) e2319
- 6 Pietrobon D, Negro-Marquínez L, Kilstein J, Galíndez J, Greca A, Battagliotti C. Disseminated histoplasmosis and AIDS in an Argentine hospital: clinical manifestations, diagnosis and treatment [in Spanish]. Enferm Infecc Microbiol Clin 2004; 22 (3) 156-159
- 7 Tobón AM, Agudelo CA, Rosero DS , et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005; 73 (3) 576-582
- 8 Mata-Essayag S, Colella MT, Roselló A , et al. Histoplasmosis: a study of 158 cases in Venezuela, 2000-2005. Medicine (Baltimore) 2008; 87 (4) 193-202
- 9 Segura L, Rojas M, Pelaez N , et al. Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala. Clin Infect Dis 1997; 25 (2) 343-344
- 10 Gutierrez ME, Canton A, Sosa N, Puga E, Talavera L. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis 2005; 40 (8) 1199-1202
- 11 Arango M, Castañeda E, Agudelo CI , et al; Colombian Histoplasmosis Study Group. Histoplasmosis: results of the Colombian national survey, 1992-2008. Biomedica 2011; 31 (3) 344-356
- 12 Antinori S, Magni C, Nebuloni M , et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85 (1) 22-36
- 13 Peigne V, Dromer F, Elie C, Lidove O, Lortholary O ; French Mycosis Study Group. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Am J Trop Med Hyg 2011; 85 (5) 934-941
- 14 Farina C, Rizzi M, Ricci L, Gabbi E, Caligaris S, Goglio A. Imported and autochthonous histoplasmosis in Italy: new cases and old problems. Rev Iberoam Micol 2005; 22 (3) 169-171
- 15 Pan B, Chen M, Pan W, Liao W. Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses 2013; 56 (3) 212-221
- 16 Wen FQ, Sun YD, Watanabe K, Yoshida M, Wu JN, Baum GL. Prevalence of histoplasmin sensitivity in healthy adults and tuberculosis patients in southwest China. J Med Vet Mycol 1996; 34 (3) 171-174
- 17 Norkaew T, Ohno H, Sriburee P , et al. Detection of environmental sources of Histoplasma capsulatum in Chiang Mai, Thailand, by nested PCR. Mycopathologia 2013; 176 (5-6) 395-402
- 18 Rangwala F, Putcharoen O, Bowonwatanuwong C , et al. Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review. Southeast Asian J Trop Med Public Health 2012; 43 (2) 436-441
- 19 Bulmer AC, Bulmer GS. Incidence of histoplasmin hypersensitivity in the Philippines. Mycopathologia 2001; 149 (2) 69-71
- 20 Lofgren SM, Kirsch EJ, Maro VP , et al. Histoplasmosis among hospitalized febrile patients in northern Tanzania. Trans R Soc Trop Med Hyg 2012; 106 (8) 504-507
- 21 Gumbo T, Just-Nübling G, Robertson V, Latif AS, Borok MZ, Hohle R. Clinicopathological features of cutaneous histoplasmosis in human immunodeficiency virus-infected patients in Zimbabwe. Trans R Soc Trop Med Hyg 2001; 95 (6) 635-636
- 22 K Ramdial P, Mosam A, Dlova NC, , B Satar N, Aboobaker J, Singh SM. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol 2002; 29 (4) 215-225
- 23 Wadhwa A, Kaur R, Agarwal SK, Jain S, Bhalla P. AIDS-related opportunistic mycoses seen in a tertiary care hospital in North India. J Med Microbiol 2007; 56 (Pt 8) 1101-1106
- 24 Gopalakrishnan R, Nambi PS, Ramasubramanian V, Abdul Ghafur K, Parameswaran A. Histoplasmosis in India: truly uncommon or uncommonly recognised?. J Assoc Physicians India 2012; 60: 25-28
- 25 Adenis AA, Aznar C, Couppié P. Histoplasmosis in HIV-infected patients: a review of new developments and remaining gaps. Curr Trop Med Rep 2014; 1: 119-128
- 26 Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14 (12) 1587-1591
- 27 Swartzentruber S, Rhodes L, Kurkjian K , et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis 2009; 49 (12) 1878-1882
- 28 Hage CA, Ribes JA, Wengenack NL , et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53 (5) 448-454
- 29 Assi M, Martin S, Wheat LJ , et al. Histoplasmosis after solid organ transplant. Clin Infect Dis 2013; 57 (11) 1542-1549
- 30 Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 2007; 86 (3) 162-169
- 31 Myint T, Anderson AM, Sanchez A , et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore) 2014; 93 (1) 11-18
- 32 Hage CA, Bowyer S, Tarvin SE, Helper D, Kleiman MB, Wheat LJ. Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis 2010; 50 (1) 85-92
- 33 Hage CA, Davis TE, Fuller D , et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest 2010; 137 (3) 623-628
- 34 Hage CA, Kirsch EJ, Stump TE , et al. Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS determined by a quantitative antigen enzyme immunoassay. Clin Vaccine Immunol 2011; 18 (4) 661-666
- 35 Wheat J, French ML, Kohler RB , et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med 1982; 97 (5) 680-685
- 36 Babady NE, Buckwalter SP, Hall L, Le Febre KM, Binnicker MJ, Wengenack NL. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011; 49 (9) 3204-3208
- 37 Scheel CM, Zhou Y, Theodoro RC, Abrams B, Balajee SA, Litvintseva AP. Development of a loop-mediated isothermal amplification method for detection of Histoplasma capsulatum DNA in clinical samples. J Clin Microbiol 2014; 52 (2) 483-488
- 38 Reynolds III RJI, Penn RL, Grafton WD, George RB. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis. Am Rev Respir Dis 1984; 130 (2) 317-320
- 39 Sollod N. Acute fulminating disseminated histoplasmosis. Report of an unusual outbreak. J S C Med Assoc 1971; 67 (5) 231-234
- 40 Sathapatayavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983; 62 (5) 263-270
- 41 Wheat LJ, Slama TG, Norton JA , et al. Risk factors for disseminated or fatal histoplasmosis. Analysis of a large urban outbreak. Ann Intern Med 1982; 96 (2) 159-163
- 42 Wynne JW, Olsen GN. Acute histoplasmosis presenting as the adult respiratory distress syndrome. Chest 1974; 66 (2) 158-161
- 43 Johnson PC, Wheat LJ, Cloud GA , et al; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137 (2) 105-109
- 44 Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984; 63 (4) 201-209
- 45 Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore) 2007; 86 (4) 252-258
- 46 Goodwin Jr RA, Owens FT, Snell JD , et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976; 55 (6) 413-452
- 47 Wheat LJ, Freifeld AG, Kleiman MB , et al; Infectious Diseases Society of America. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45 (7) 807-825
- 48 Limper AH, Knox KS, Sarosi GA , et al; American Thoracic Society Fungal Working Group. An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011; 183 (1) 96-128
- 49 Furcolow ML. Comparison of treated and untreated severe histoplasmosis. JAMA 1963; 183 (10) 823-829
- 50 Putnam LR, Sutliff WD, Larkin JC , et al. Histoplasmosis cooperative study: Chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide. Am Rev Respir Dis 1968; 97 (1) 96-102
- 51 Mukhopadhyay S, Wilcox BE, Myers JL , et al. Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules. Chest 2013; 144 (3) 813-824
- 52 Mashburn JD, Dawson DF, Young JM. Pulmonary calcifications and histoplasmosis. Am Rev Respir Dis 1961; 84: 208-216
- 53 Straub M, Schwarz J. The healed primary complex in histoplasmosis. Am J Clin Pathol 1955; 25 (7) 727-741
- 54 Deppen S, Putnam Jr JB, Andrade G , et al. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg 2011; 92 (2) 428-432 , discussion 433
- 55 Kadaria D, Archie DS, SultanAli I, Weiman DS, Freire AX, Zaman MK. Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis. Am J Med Sci 2013; 346 (5) 358-362
- 56 Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003; 348 (25) 2535-2542
- 57 Goodwin RA, Alcorn GL. Histoplasmosis with symptomatic lymphadenopathy. Chest 1980; 77 (2) 213-215
- 58 Goodwin RA, Loyd JE, Des Prez RM. Histoplasmosis in normal hosts. Medicine (Baltimore) 1981; 60 (4) 231-266
- 59 Parish JM, Rosenow III EC. Mediastinal granuloma and mediastinal fibrosis. Semin Respir Crit Care Med 2002; 23 (2) 135-143
- 60 Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972; 51 (3) 227-246
- 61 Johnson JA, Loyd JE, Wheat LJ, Netterville JL. A case series and review of histoplasmosis infection in the neck. Arch Otolaryngol Head Neck Surg 2010; 136 (9) 916-919
- 62 Savides TJ, Gress FG, Wheat LJ, Ikenberry S, Hawes RH. Dysphagia due to mediastinal granulomas: diagnosis with endoscopic ultrasonography. Gastroenterology 1995; 109 (2) 366-373
- 63 Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1991. A 46-year-old man with fever, a cough, and bilateral pulmonary nodules. N Engl J Med 1991; 325 (13) 949-956
- 64 Dines DE, Payne WS, Bernatz PE, Pairolero PC. Mediastinal granuloma and fibrosing mediastinitis. Chest 1979; 75 (3) 320-324
- 65 Loyd JE, Tillman BF, Atkinson JB, Des Prez RM. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) 1988; 67 (5) 295-310
- 66 Martin JB, Prudhomme JB, Scott TA, Loyd JE. Features associated with mortality in fibrosing mediastinitis. Am J Respir Crit Care Med 2005; 2: A204
- 67 Peikert T, Colby TV, Midthun DE , et al. Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) 2011; 90 (6) 412-423
- 68 Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med 2014; 190 (9) 1069-1071
- 69 Albers EL, Pugh ME, Hill KD, Wang L, Loyd JE, Doyle TP. Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. Circulation 2011; 123 (13) 1391-1399
- 70 Recto MR, Bousamra M, Yeh Jr T. Late superior vena cava perforation and aortic laceration after stenting to treat superior vena cava syndrome secondary to fibrosing mediastinitis. J Invasive Cardiol 2002; 14 (10) 624-629
- 71 Vinh DC. Insights into human antifungal immunity from primary immunodeficiencies. Lancet Infect Dis 2011; 11 (10) 780-792
- 72 Lionakis MS, Holland SM. Human invasive mycoses: immunogenetics on the rise. J Infect Dis 2015; 211 (8) 1205-1207
- 73 Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr 2007; 166 (11) 1099-1117
- 74 Kortsik C, Elmer A, Tamm I. Pleural effusion due to Histoplasma capsulatum and idiopathic CD4 lymphocytopenia. Respiration 2003; 70 (1) 118-122
- 75 Alberti-Flor JJ, Granda A. Ileocecal histoplasmosis mimicking Crohn's disease in a patient with Job's syndrome. Digestion 1986; 33 (3) 176-180
- 76 Robinson WS, Arnold SR, Michael CF , et al. Case report of a young child with disseminated histoplasmosis and review of hyper immunoglobulin e syndrome (HIES). Clin Mol Allergy 2011; 9: 14
- 77 Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005; 41 (4) e38-e41
- 78 Conces Jr DJ, Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol 1993; 160 (1) 15-19
- 79 Riddell IV J, Kauffman CA, Smith JA , et al. Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore) 2014; 93 (5) 186-193
- 80 La Hoz RM, Loyd JE, Wheat LJ, Baddley JW, How I. Treat histoplasmosis. Curr Fungal Infect Rep 2012; 2014: 23
- 81 Wheat J, MaWhinney S, Hafner R , et al; National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am J Med 1997; 103 (3) 223-232
- 82 Restrepo A, Tobón A, Clark B , et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007; 54 (4) 319-327
- 83 Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7 (3–4) 109-115
- 84 Wheat LJ, Connolly P, Smedema M , et al. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother 2006; 57 (6) 1235-1239
- 85 Kraft WK, Chang PS, van Iersel ML, Waskin H, Krishna G, Kersemaekers WM. Posaconazole tablet pharmacokinetics: lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects. Antimicrob Agents Chemother 2014; 58 (7) 4020-4025
- 86 Maertens J, Cornely OA, Ullmann AJ , et al. Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease. Antimicrob Agents Chemother 2014; 58 (7) 3610-3617
- 87 Duplessis CA, Tilley D, Bavaro M, Hale B, Holland SM. Two cases illustrating successful adjunctive interferon-γ immunotherapy in refractory disseminated coccidioidomycosis. J Infect 2011; 63 (3) 223-228
- 88 Ibrahim KY, Carvalho NB, Mimicos EV, Yeh-Li H, Sotto MN, França FO. Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant. Mycopathologia 2014; 178 (3-4) 273-278
- 89 Cuellar-Rodriguez J, Avery RK, Lard M , et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49 (5) 710-716
- 90 Grim SA, Proia L, Miller R , et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14 (1) 17-23
- 91 Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis 2011; 11: 145
- 92 Dotson JL, Crandall W, Mousa H , et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis 2011; 17 (1) 56-61